From the journal:

RSC Medicinal Chemistry

Correction: Novel small molecule derivatives improve survivability in the cellular model of Huntington's disease via improving mitochondrial fusion

Pradeep Kodam,a   Vaishali Kumar,a   Paramita Pattanayak,b   Praharsh Vitta,a   Tanmay Chatterjee*b  and  Shuvadeep Maity*a  

* Corresponding authors

a Department of Biological Science, Birla Institute of Technology and Science, Pilani, Hyderabad Campus, Jawahar Nagar, Kapra Mandal, Medchal District, Telangana 500078, India
E-mail: shuvadeep@hyderabad.bits-pilani.ac.in

b Department of Chemistry, Birla Institute of Technology and Science, Pilani, Hyderabad Campus, Jawahar Nagar, Kapra Mandal, Medchal District, Telangana 500078, India
E-mail: tanmay@hyderabad.bits-pilani.ac.in

Abstract

Correction for ‘Novel small molecule derivatives improve survivability in the cellular model of Huntington's disease via improving mitochondrial fusion’ by Pradeep Kodam et al., RSC Med. Chem., 2026, https://doi.org/10.1039/d5md00345h.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D5MD90052B
Article type
Correction
Submitted
05 Dec 2025
Accepted
05 Dec 2025
First published
11 Dec 2025
This article is Open Access
Creative Commons BY license

RSC Med. Chem., 2026, Advance Article

Permissions

Request permissions

Correction: Novel small molecule derivatives improve survivability in the cellular model of Huntington's disease via improving mitochondrial fusion

P. Kodam, V. Kumar, P. Pattanayak, P. Vitta, T. Chatterjee and S. Maity, RSC Med. Chem., 2026, Advance Article , DOI: 10.1039/D5MD90052B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements